SCHEMBL29673144

SCHEMBL29673144

O=C(O)CCc1ccc(F)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 2/20 0.50
KDM4E B2RXH2 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.50
HPGD P15428 1/20 0.50
MAPK1 P28482 1/20 0.50
CYP2C19 P33261 1/20 0.50
FFAR4 Q5NUL3 5/20 0.49
FFAR1 O14842 5/20 0.49
HSD11B1 P28845 1/20 0.46
POLB P06746 1/20 0.45
GPR17 Q13304 1/20 0.45
NPSR1 Q6W5P4 2/20 0.44
RXRA P19793 2/20 0.43
RXRB P28702 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5045620 1.00 MEN1 (0.50) MEN1KMT2AALDH1A1KDM4ECYP1A2
SCHEMBL24543320 0.91 MEN1 (0.49) MEN1KMT2AALDH1A1KDM4ECYP1A2
SCHEMBL29673072 0.91 MEN1 (0.49) MEN1KMT2AALDH1A1KDM4ECYP1A2
SCHEMBL8361243 0.86 MEN1 (0.44) MEN1KMT2AALDH1A1KDM4ECYP1A2
SCHEMBL5427170 0.86 FFAR1 (0.49) MEN1KMT2AALDH1A1KDM4ECYP1A2
SCHEMBL2831742 0.84 MPO (0.54) MEN1KMT2AALDH1A1KDM4ECYP1A2
SCHEMBL30911087 0.81 MEN1 (0.52) MEN1KMT2AALDH1A1KDM4ECYP1A2
SCHEMBL586345 0.81 PDPK1 (0.59) ALDH1A1HPGDFFAR1GPR17
SCHEMBL30567601 0.81 PDPK1 (0.59) ALDH1A1HPGDFFAR1GPR17
SCHEMBL1699587 0.81 MEN1 (0.52) MEN1KMT2AALDH1A1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022127827-A1 KRASG12C PROTEIN MUTATION INHIBITOR AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF 上海维申医药有限公司 2022-06-23 WO disclosed
CN-114644631-A KRAS G12C protein mutation inhibitor, preparation method thereof, pharmaceutical composition and application thereof 上海维申医药有限公司 2022-06-21 CN disclosed